SML0097

Nevirapine

≥98% (HPLC), HIV-1 reverse transcriptase inhibitor, powder

• Synonim(y): 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one
• Wzór empiryczny (zapis Hilla): C₁₅H₁₄N₄O
• Numer CAS: 129618-40-2
• Masa cząsteczkowa: 266.30
• UNSPSC Code: 12352200
• PubChem Substance ID: 329825155
• NACRES: NA.77
• MDL number: MFCD00866928
• Assay: ≥98% (HPLC)
• Form: powder

Właściwości

• Nazwa produktu: Nevirapine,
• assay: ≥98% (HPLC)
• Quality Segment: 100
• form: powder
• color: white to tan
• solubility: DMSO: ≥22 mg/mL
• storage temp.: room temp
• SMILES string: CC1=CC=NC2=C1NC(C(C=CC=N3)=C3N2C4CC4)=O
• InChI: 1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)
• InChI key: NQDJXKOVJZTUJA-UHFFFAOYSA-N

Opis

Application

Nevirapine has been used as non-nucleoside reverse transcriptase inhibitor in in vitro porcine endogenous retrovirus replication, primary hepatocytes and bone marrow dendritic cells (BMDCs).

Biochem/physiol Actions

NNRTI (non-nucleoside reverse transcriptase inhibitor) of HIV-1

Nevirapine is an allosteric, non-nucleoside inhibitor of HIV reverse transcriptase (NNRTI). The K_i for inhibition of wild-type RT by Nevirapine is 200 nM.

Nevirapine interacts with glycine 190 residue of human immuno deficiency virus (HIV-2) reverse transcriptase. It is an antiretroviral drug which increases bile synthesis and activates electron transport chain. Use of nevirapine leads to liver toxicity and is associated with Nevirapine hypersensitivity syndrome.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 2
• flash_point_f: Not applicable
• flash_point_c: Not applicable